For representation: In this Saturday, July 13, 2019 file photo, health workers wearing protective suits tend to an Ebola victim kept in an isolation tent in Beni, Democratic Republic of Congo. On Wednesday, Oct. 14, 2020, the U.S. Food and Drug Administration said it has approved Inmazeb, a drug made by Regeneron, for treating Ebola in both adults and children. (AP Photo/Jerome Delay)
This article is auto-generated by AlgorithmSource: www.news18.com